Scientific Industries (OTCQB:SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems and methods. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com.
Company profile
Ticker
SCND
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Revvity • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Seer • Prenetics Global Limited ...
SEC CIK
Corporate docs
IRS number
42217279
Latest filings (excl ownership)
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
17 Apr 23
10-KT
Annual report (with FYE transition)
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Changes in Registrant's Certifying Accountant
22 Dec 22
DEF 14A
Definitive proxy
20 Dec 22
8-K
Changes in Registrant's Certifying Accountant
1 Dec 22
10-Q
2022 Q1
Quarterly report
14 Nov 22
8-K
Amendments to Articles of Incorporation or Bylaws
9 Nov 22
10-K
2022 FY
Annual report
28 Sep 22
Latest ownership filings
SC 13G/A
LYTTON LAURENCE W
7 Mar 23
SC 13D/A
EDDLEMAN ROY T
15 Feb 23
SC 13G/A
Bleichroeder LP
14 Feb 23
SC 13G/A
Veradace Capital Management LLC
14 Feb 23
SC 13G/A
LYTTON LAURENCE W
13 Feb 23
SC 13G/A
SATTERFIELD THOMAS A JR
10 Feb 23
3
Reginald Averilla
13 Jul 22
4
JOSEPH G CREMONESE
9 Jun 22
4
JOSEPH G CREMONESE
9 Jun 22
4
JOSEPH G CREMONESE
8 Jun 22
Financial summary
| Quarter (USD) | Mar 23 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.08 mm | 1.08 mm | 1.08 mm | 1.08 mm | 1.08 mm | 1.08 mm |
| Cash burn (monthly) | 452.77 k | 268.13 k | 822.53 k | 1.05 mm | 581.57 k | 515.76 k |
| Cash used (since last report) | 1.00 mm | 594.89 k | 1.82 mm | 2.33 mm | 1.29 mm | 1.14 mm |
| Cash remaining | 74.88 k | 484.51 k | -745.49 k | -1.25 mm | -210.87 k | -64.87 k |
| Runway (months of cash) | 0.2 | 1.8 | -0.9 | -1.2 | -0.4 | -0.1 |
Institutional ownership, Q4 2022
26.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 1 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 1.86 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Veradace Capital Management | 953.72 k | $0.00 |
| Bleichroeder | 905.03 k | $0.00 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jun 22 | Cremonese Joseph G | Common Stock | Sell | Dispose S | Yes | No | 5.18 | 3,600 | 18.65 k | 120,062 |
| 9 Jun 22 | Cremonese Joseph G | Common Stock | Sell | Dispose S | No | No | 5.18 | 4,000 | 20.72 k | 116,062 |
| 6 Jun 22 | Cremonese Joseph G | Common Stock | Sell | Dispose S | No | No | 5.1 | 400 | 2.04 k | 123,662 |
| 27 May 22 | Cremonese Joseph G | Common Stock | Sell | Dispose S | Yes | No | 5 | 1,000 | 5.00 k | 124,062 |
Press releases
Scientific Industries to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and Hosted by M-Vest on Thursday, June 1, 2023 at 9:00 A.M. ET
31 May 23
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2023
16 May 23
Scientific Industries to Report First Quarter 2023 Financial Results on May 15, 2023
11 May 23
Scientific Industries Reports Financial Results for Six Month Transition Period Ended December 31, 2022; Discloses Non-Cash Restatement of Certain Previously Issued Financial Statements
17 Apr 23